Chargement en cours...
CELLULAR AND MOLECULAR IMMUNOLOGY OF LUNG CANCER: THERAPEUTIC IMPLICATIONS
Though incidence is declining, the prognosis of lung cancer remains poor. This is likely due to lack of early detection and only recent developments in selective cancer therapies. Key immune cells involved in the pathogenesis of lung cancer include CD4(+) T-lymphocytes, macrophages, dendritic cells,...
Enregistré dans:
| Publié dans: | Expert Rev Clin Immunol |
|---|---|
| Auteurs principaux: | , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
2014
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4596236/ https://ncbi.nlm.nih.gov/pubmed/25351434 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1586/1744666X.2014.975692 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|